EDN1 and endothelial dysfunction: Activation of autoantibodies and cell-mediated autoimmunity, through the mediation of endothelin 1 (ET-1), may also lead to endothelial dysfunction and development of microvascular endothelial cells/small vessels fibroproliferative vasculopathy, with subsequently chronic ischemia of the affected tissues [24].